Alphatec Holdings Inc
$ 7.68
2.67%
03 Jun - close price
- Market Cap 1,181,102,000 USD
- Current Price $ 7.68
- High / Low $ 7.77 / 7.39
- Stock P/E N/A
- Book Value -0.04
- EPS -0.83
- Next Earning Report 2026-07-30
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.04 %
- ROE -6.31 %
- 52 Week High 23.29
- 52 Week Low 6.82
About
Alphatec Holdings, Inc., a medical technology company, designs, develops and advances technologies for the surgical treatment of spinal disorders. The company is headquartered in Carlsbad, California.
Analyst Target Price
$16.73
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-05 | 2026-02-24 | 2025-10-30 | 2025-07-31 | 2025-05-01 | 2025-02-26 | 2024-10-30 | 2024-07-31 | 2024-05-07 | 2024-02-27 | 2023-11-06 | 2023-08-03 |
| Reported EPS | -0.2201 | 0.06 | -0.19 | 0.02 | -0.35 | -0.0638 | -0.13 | -0.14 | -0.16 | -0.37 | -0.11 | -0.12 |
| Estimated EPS | -0.0036 | 0.0375 | -0.16 | -0.04 | -0.24 | -0.0375 | -0.11 | -0.12 | -0.14 | -0.25 | -0.08 | -0.12 |
| Surprise | -0.2165 | 0.0225 | -0.03 | 0.06 | -0.11 | -0.0263 | -0.02 | -0.02 | -0.02 | -0.12 | -0.03 | 0 |
| Surprise Percentage | -6013.8889% | 60% | -18.75% | 150% | -45.8333% | -70.1333% | -18.1818% | -16.6667% | -14.2857% | -48% | -37.5% | 0% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-30 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.07 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ATEC
2026-06-03 21:10:35
Bragar Eagel & Squire, P.C. is investigating potential claims against Alphatec Holdings, Inc. on behalf of Alphatec stockholders. This investigation follows Alphatec's first-quarter 2026 financial results, which missed revenue estimates and led to a stock price drop after the company reduced its full-year EOS revenue outlook. The law firm is encouraging investors who suffered losses to contact them to discuss their legal options.
2026-06-02 11:00:00
Bronstein, Gewirtz & Grossman, LLC is investigating Alphatec Holdings, Inc. (NASDAQ:ATEC) following the company's Q1 2026 financial results which missed revenue estimates and reduced its full-year EOS revenue outlook. The investigation encourages shareholders to connect with the firm to learn more and potentially assist in a class action claim. The firm operates on a contingency fee basis, aiming to recover investor capital due to alleged securities fraud.
2026-06-02 09:31:08
Alphatec (ATEC) is trading at $7.96, significantly below its 52-week high, categorizing it as a potentially "cheap stock" despite Q1 2026 earnings misses and an ongoing securities fraud investigation. The company shows strong surgical revenue growth and recent strategic debt refinancing, yet faces challenges with profitability and execution in its EOS segment. Analysts maintain a "Moderate Buy" rating with substantial upside potential, but investors need to weigh these opportunities against the inherent risks and the need for consistent operational improvements and profitability.
2026-06-01 22:10:46
Alphatec Holdings Inc. (NASDAQ: ATEC) is highlighted as a top cheap stock under $10 to buy in June, following strong Q1 2026 financial results with significant revenue growth and improved EBITDA. The company, focused on spinal disorder solutions, projects continued growth and free cash flow generation for the full year 2026. Despite its potential, the article also promotes other AI-related investment opportunities, suggesting they might offer higher returns in a shorter timeframe.
2026-06-01 20:39:17
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Alphatec Holdings, Inc. (ATEC) following a significant drop in its stock price. This comes after Alphatec missed first-quarter 2026 revenue estimates and reduced its full-year EOS revenue outlook, citing challenges in delivering units. Investors who purchased Alphatec securities are encouraged to contact the firm to learn more about the investigation.
2026-06-01 11:09:41
Alphatec (ATEC) reported Q4 earnings of $0.06 per share, exceeding the Zacks Consensus Estimate of $0.04 and improving significantly from a loss of $0.23 per share a year ago. The company also surpassed revenue estimates, posting $212.93 million against a consensus of $212.65 million. Despite these positive results, Alphatec's stock has declined by 37.5% year-to-date, contrasting with the S&P 500's minor decline.
